Editor

• Dr Robert McDowall, Consultant, McDowall Consulting (UK)

Assistant Editor

• Dr Carlos Horkan, Director Pharma Division, RCWG Ltd (UK)

Editorial Board Members

• Dr Lajos Hajdu, Manager System Administration, Senior Validation Engineer, AstraZeneca Drug Product Supply (Sweden)
• Dr Christopher Burgess, Consultant, Burgess Consultancy (UK)
• Tom Davis, Validation Manager, Eli Lilly (Ireland)
• Linda Liong, Clinical Data Management Co-ordinator, Lilly-NUS (Singapore)
• Irina Colligan, Principal Consultant, PAREXEL Consulting (USA)
• Victoria Lander, Compliance Development Manager, Waters Corporation (USA)
• Dr Thomas Fuchs, Head of Global e-Compliance, Novartis Pharma AG (Switzerland)
• Juan O. Perez, Director, QCSV, Inc. (Puerto Rico)
• Peter Burton, Director, Sterling Process Automation (Australia)
• David Harrisson, Senior Consultant, ABB (UK)
• Berkeley Wilson, IT Manger, Ego Pharmaceuticals (Australia)
• Neil Konopka, Head of European Regulatory Affairs, PhaseForward (UK)
• Earl W. Hulihan, Vice President of Regulator Affairs and Quality Assurance, Medidata Solutions, Inc. (USA)